Gofen & Glossberg’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.01M | Sell |
13,172
-149
| -1% | -$11.3K | 0.03% | 241 |
|
|
2022
Q3 | $888K | Buy |
13,321
+4
| +0% | +$254 | 0.03% | 242 |
|
|
2022
Q2 | $696K | Buy |
13,317
+3
| +0% | +$171 | 0.02% | 270 |
|
|
2022
Q1 | $755K | Buy |
13,314
+3
| +0% | +$161 | 0.02% | 275 |
|
|
2021
Q4 | $685K | Buy |
13,311
+4
| +0% | +$196 | 0.01% | 298 |
|
|
2021
Q3 | $658K | Buy |
13,307
+156
| +1% | +$8.46K | 0.02% | 296 |
|
|
2021
Q2 | $751K | Buy |
13,151
+184
| +1% | +$10.8K | 0.02% | 274 |
|
|
2021
Q1 | $788K | Buy |
12,967
+3
| +0% | +$166 | 0.02% | 263 |
|
|
2020
Q4 | $694K | Sell |
12,964
-296
| -2% | -$15.4K | 0.02% | 270 |
|
|
2020
Q3 | $623K | Buy |
13,260
+3
| +0% | +$154 | 0.02% | 265 |
|
|
2020
Q2 | $692K | Sell |
13,257
-134
| -1% | -$6.91K | 0.02% | 240 |
|
|
2020
Q1 | $642K | Sell |
13,391
-245
| -2% | -$12.7K | 0.03% | 236 |
|
|
2019
Q4 | $690K | Buy |
13,636
+350
| +3% | +$18.1K | 0.02% | 255 |
|
|
2019
Q3 | $627K | Buy |
13,286
+3
| +0% | +$137 | 0.02% | 254 |
|
|
2019
Q2 | $626K | Buy |
13,283
+2
| +0% | +$92 | 0.02% | 257 |
|
|
2019
Q1 | $639K | Buy |
13,281
+3
| +0% | +$150 | 0.02% | 242 |
|
|
2018
Q4 | $592K | Buy |
13,278
+2
| +0% | +$104 | 0.02% | 243 |
|
|
2018
Q3 | $717K | Buy |
13,276
+2
| +0% | +$102 | 0.02% | 237 |
|
|
2018
Q2 | $648K | Buy |
13,274
+2
| +0% | +$113 | 0.02% | 241 |
|
|
2018
Q1 | $832K | Buy |
13,272
+2
| +0% | +$137 | 0.03% | 222 |
|
|
2017
Q4 | $813K | Buy |
13,270
+1
| +0% | +$62 | 0.03% | 234 |
|
|
2017
Q3 | $888K | Buy |
13,269
+2
| +0% | +$141 | 0.03% | 225 |
|
|
2017
Q2 | $1.03M | Sell |
13,267
-872
| -6% | -$65.8K | 0.04% | 210 |
|
|
2017
Q1 | $1.15M | Buy |
14,139
+550
| +4% | +$43.3K | 0.05% | 203 |
|
|
2016
Q4 | $978K | Buy |
13,589
+1
| +0% | +$72 | 0.04% | 208 |
|
|
2016
Q3 | $1.06M | Sell |
13,588
-8
| -0.1% | -$647 | 0.04% | 198 |
|
|
2016
Q2 | $1.06M | Sell |
13,596
-152
| -1% | -$12.1K | 0.04% | 195 |
|
|
2016
Q1 | $1.13M | Buy |
13,748
+164
| +1% | +$13.3K | 0.05% | 188 |
|
|
2015
Q4 | $1.21M | Sell |
13,584
-914
| -6% | -$77.6K | 0.05% | 188 |
|
|
2015
Q3 | $1.11M | Buy |
14,498
+1
| +0% | +$84 | 0.05% | 197 |
|
|
2015
Q2 | $1.21M | Sell |
14,497
-179
| -1% | -$15.8K | 0.05% | 195 |
|
|
2015
Q1 | $1.32M | Buy |
14,676
+755
| +5% | +$65K | 0.06% | 192 |
|
|
2014
Q4 | $1.12M | Buy |
13,921
+2
| +0% | +$158 | 0.05% | 203 |
|
|
2014
Q3 | $1.04M | Buy |
13,919
+1
| +0% | +$73 | 0.05% | 201 |
|
|
2014
Q2 | $954K | Buy |
13,918
+735
| +6% | +$50K | 0.04% | 206 |
|
|
2014
Q1 | $943K | Buy |
13,183
+1
| +0% | +$70 | 0.04% | 204 |
|
|
2013
Q4 | $881K | Buy |
13,182
+1
| +0% | +$61 | 0.04% | 207 |
|
|
2013
Q3 | $687K | Buy |
13,181
+1
| +0% | +$51 | 0.04% | 217 |
|
|
2013
Q2 | $622K | Buy |
+13,180
| New | +$602K | 0.03% | 216 |
|
Other funds holding CAH
Gofen & Glossberg's CAH Position: Q4 2022 in Review
Gofen & Glossberg reduced its Cardinal Health (CAH) stake by 1.1% in Q4 2022, selling an estimated $11.3K and leaving 13,172 shares worth $1.01M. The position accounts for 0.03% of the portfolio, ranked #241.
Gofen & Glossberg first reported a position in CAH in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.32M in Q1 2015. 931 funds tracked by Wall St. Rank hold CAH as of Q4 2022.
- Gofen & Glossberg held 13,172 shares of Cardinal Health worth $1.01M as of Q4 2022.
- Gofen & Glossberg sold 149 Cardinal Health shares in Q4 2022, an estimated $11.3K.
- Cardinal Health made up 0.03% of Gofen & Glossberg's portfolio in Q4 2022, its #241 holding.
- Gofen & Glossberg first reported a position in Cardinal Health in Q2 2013 and has held it in 39 quarters since.
- Gofen & Glossberg's Cardinal Health position peaked at $1.32M in Q1 2015.
- 931 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2022.
Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.